Is HUTCHMED DRC Stock a Good Investment?
HUTCHMED DRC Investment Advice | HCM |
- Examine HUTCHMED DRC's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research HUTCHMED DRC's leadership team and their track record. Good management can help HUTCHMED DRC navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact HUTCHMED DRC's business and its evolving consumer preferences.
- Compare HUTCHMED DRC's performance and market position to its competitors. Analyze how HUTCHMED DRC is positioned in terms of product offerings, innovation, and market share.
- Check if HUTCHMED DRC pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about HUTCHMED DRC's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in HUTCHMED DRC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if HUTCHMED DRC is a good investment.
Sell | Buy |
Sell
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine HUTCHMED DRC Stock
Researching HUTCHMED DRC's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The book value of the company was currently reported as 0.87. The company has Price/Earnings (P/E) ratio of 335.94. HUTCHMED DRC had not issued any dividends in recent years. The entity had 1:1 split on the 30th of May 2019.
To determine if HUTCHMED DRC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding HUTCHMED DRC's research are outlined below:
| HUTCHMED DRC had very high historical volatility over the last 90 days | |
| Latest headline from finance.yahoo.com: Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community |
HUTCHMED DRC Quarterly Liabilities And Stockholders Equity |
|
HUTCHMED DRC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in HUTCHMED DRC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to HUTCHMED DRC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact HUTCHMED DRC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises HUTCHMED DRC's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-07-27 | 2018-06-30 | -0.16 | -0.14 | 0.02 | 12 | ||
2018-05-30 | 2018-03-31 | -0.16 | -0.14 | 0.02 | 12 | ||
2020-11-13 | 2020-09-30 | -0.2052 | -0.1845 | 0.0207 | 10 | ||
2019-05-29 | 2019-03-31 | -0.13 | -0.1547 | -0.0247 | 19 | ||
2019-11-15 | 2019-09-30 | -0.17 | -0.1287 | 0.0413 | 24 | ||
2020-06-03 | 2020-03-31 | -0.32 | -0.2652 | 0.0548 | 17 | ||
2017-07-31 | 2017-06-30 | 0.09 | 0.03 | -0.06 | 66 | ||
2016-08-02 | 2016-06-30 | -0.06 | 0.01 | 0.07 | 116 |
Know HUTCHMED DRC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as HUTCHMED DRC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HUTCHMED DRC backward and forwards among themselves. HUTCHMED DRC's institutional investor refers to the entity that pools money to purchase HUTCHMED DRC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goldman Sachs Group Inc | 2024-12-31 | 86.6 K | Hennion & Walsh Asset Management Inc | 2024-12-31 | 60 K | Two Sigma Investments Llc | 2024-12-31 | 58.5 K | Xy Capital Ltd | 2024-12-31 | 46.7 K | D. E. Shaw & Co Lp | 2024-12-31 | 41.5 K | Dekabank Deutsche Girozentrale | 2024-12-31 | 41.4 K | Bnp Paribas Arbitrage, Sa | 2024-12-31 | 39.6 K | Citadel Advisors Llc | 2024-12-31 | 36.5 K | Abc Arbitrage Sa | 2024-12-31 | 34.7 K | Schroder Investment Management Group | 2024-12-31 | 2.8 M | Allianz Asset Management Ag | 2024-12-31 | 1.1 M |
HUTCHMED DRC's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 2.76 B.Market Cap |
|
HUTCHMED DRC's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.02 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.05 | 0.05 |
Determining HUTCHMED DRC's profitability involves analyzing its financial statements and using various financial metrics to determine if HUTCHMED DRC is a good buy. For example, gross profit margin measures HUTCHMED DRC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of HUTCHMED DRC's profitability and make more informed investment decisions.
Evaluate HUTCHMED DRC's management efficiency
HUTCHMED DRC has Return on Asset of (0.059) % which means that on every $100 spent on assets, it lost $0.059. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0544) %, meaning that it generated no profit with money invested by stockholders. HUTCHMED DRC's management efficiency ratios could be used to measure how well HUTCHMED DRC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of March 2025, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.03. At this time, HUTCHMED DRC's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.79 | 0.83 | |
| Tangible Book Value Per Share | 0.79 | 0.83 | |
| Enterprise Value Over EBITDA | (4.55) | (4.77) | |
| Price Book Value Ratio | 4.80 | 4.56 | |
| Enterprise Value Multiple | (4.55) | (4.77) | |
| Price Fair Value | 4.80 | 4.56 | |
| Enterprise Value | 2.6 B | 3.3 B |
HUTCHMED DRC showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 0.749 |
Basic technical analysis of HUTCHMED Stock
As of the 21st of March, HUTCHMED DRC retains the market risk adjusted performance of 0.1434, and Risk Adjusted Performance of 0.0283. HUTCHMED DRC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out HUTCHMED DRC information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if HUTCHMED DRC is priced adequately, providing market reflects its last-minute price of 14.99 per share. Given that HUTCHMED DRC has jensen alpha of 0.1048, we strongly advise you to confirm HUTCHMED DRC's regular market performance to make sure the company can sustain itself next year.HUTCHMED DRC's Outstanding Corporate Bonds
HUTCHMED DRC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HUTCHMED DRC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HUTCHMED bonds can be classified according to their maturity, which is the date when HUTCHMED DRC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand HUTCHMED DRC's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing HUTCHMED DRC's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0283 | |||
| Market Risk Adjusted Performance | 0.1434 | |||
| Mean Deviation | 2.49 | |||
| Semi Deviation | 2.96 | |||
| Downside Deviation | 3.06 | |||
| Coefficient Of Variation | 4233.0 | |||
| Standard Deviation | 3.3 | |||
| Variance | 10.89 | |||
| Information Ratio | 0.0425 | |||
| Jensen Alpha | 0.1048 | |||
| Total Risk Alpha | 0.3371 | |||
| Sortino Ratio | 0.0458 | |||
| Treynor Ratio | 0.1334 | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 6.29 | |||
| Downside Variance | 9.39 | |||
| Semi Variance | 8.78 | |||
| Expected Short fall | (2.73) | |||
| Skewness | 0.2888 | |||
| Kurtosis | 0.2701 |
| Risk Adjusted Performance | 0.0283 | |||
| Market Risk Adjusted Performance | 0.1434 | |||
| Mean Deviation | 2.49 | |||
| Semi Deviation | 2.96 | |||
| Downside Deviation | 3.06 | |||
| Coefficient Of Variation | 4233.0 | |||
| Standard Deviation | 3.3 | |||
| Variance | 10.89 | |||
| Information Ratio | 0.0425 | |||
| Jensen Alpha | 0.1048 | |||
| Total Risk Alpha | 0.3371 | |||
| Sortino Ratio | 0.0458 | |||
| Treynor Ratio | 0.1334 | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 6.29 | |||
| Downside Variance | 9.39 | |||
| Semi Variance | 8.78 | |||
| Expected Short fall | (2.73) | |||
| Skewness | 0.2888 | |||
| Kurtosis | 0.2701 |
Consider HUTCHMED DRC's intraday indicators
HUTCHMED DRC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HUTCHMED DRC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 9774.14 | |||
| Daily Balance Of Power | (1.24) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 15.25 | |||
| Day Typical Price | 15.16 | |||
| Price Action Indicator | (0.83) | |||
| Period Momentum Indicator | (1.14) | |||
| Relative Strength Index | 50.39 |
HUTCHMED DRC Corporate Filings
6K | 21st of March 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
HUTCHMED Stock media impact
Far too much social signal, news, headlines, and media speculation about HUTCHMED DRC that are available to investors today. That information is available publicly through HUTCHMED media outlets and privately through word of mouth or via HUTCHMED internal channels. However, regardless of the origin, that massive amount of HUTCHMED data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of HUTCHMED DRC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of HUTCHMED DRC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to HUTCHMED DRC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive HUTCHMED DRC alpha.
HUTCHMED DRC Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards HUTCHMED DRC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
HUTCHMED DRC Corporate Management
| Kin MBA | Senior Communications | Profile | |
| Thomas Fu | Senior Quality | Profile | |
| CA BEc | CFO Director | Profile | |
| CS CGP | Company Director | Profile | |
| Yiling Cui | Executive Operations | Profile | |
| Charles Nixon | Group Counsel | Profile | |
| Qingmei Wang | Senior Alliances | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share 0.2 | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between HUTCHMED DRC's value and its price, as these two are different measures arrived at by various means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.